APA način citiranja

Lotfi, M., & Rezaei, N. (2020). CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother.

Čikaški stil citiranja

Lotfi, Melika, i Nima Rezaei. "CRISPR/Cas13: A Potential Therapeutic Option of COVID-19." Biomed Pharmacother 2020.

MLA način citiranja

Lotfi, Melika, i Nima Rezaei. "CRISPR/Cas13: A Potential Therapeutic Option of COVID-19." Biomed Pharmacother 2020.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.